Selected research
Market Structure
Global Sleeping Pills Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Sleeping Pills market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Sleeping Pills is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Sleeping Pills is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Sleeping Pills is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Sleeping Pills is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Sleeping Pills include Abbott Laboratories, Takeda Pharmaceutical, Sanofi, Hayao, Cayman Chemical, Aurobindo Pharma, Apotex, Ambitropin and Allegiant Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Sleeping Pills market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Sleeping Pills and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Sleeping Pills sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sleeping Pills market size, projected growth trends, production technologies, key applications, and end-use industries.
Sleeping Pills Segment by Company
Abbott Laboratories
Takeda Pharmaceutical
Sanofi
Hayao
Cayman Chemical
Aurobindo Pharma
Apotex
Ambitropin
Allegiant Health
Actellon Pharmaceuticals
Sleeping Pills Segment by Type
Adapin (doxepin)
Ativan (lorazepam)
Ramelteon (Rozerem)
Eszopiclone (Lunesta)
Zolpidem
Sleeping Pills Segment by Application
Hospital Pharmacy
Retail Pharmacy
Sleeping Pills Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sleeping Pills market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sleeping Pills and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sleeping Pills.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Sleeping Pills market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sleeping Pills manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sleeping Pills in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Sleeping Pills in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Adapin (doxepin)
- Ativan (lorazepam)
- Ramelteon (Rozerem)
- Eszopiclone (Lunesta)
- Zolpidem
Applications
- Hospital Pharmacy
- Retail Pharmacy
Companies covered
- Abbott Laboratories
- Takeda Pharmaceutical
- Sanofi
- Hayao
- Cayman Chemical
- Aurobindo Pharma
- Apotex
- Ambitropin
- Allegiant Health
- Actellon Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Sleeping Pills Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Sleeping Pills Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Sleeping Pills Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Sleeping Pills Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Sleeping Pills Market Dynamics
- 2.1 Sleeping Pills Industry Trends
- 2.2 Sleeping Pills Industry Drivers
- 2.3 Sleeping Pills Industry Opportunities and Challenges
- 2.4 Sleeping Pills Industry Restraints
3 Sleeping Pills Market by Manufacturers
- 3.1 Global Sleeping Pills Revenue by Manufacturers (2021-2026)
- 3.2 Global Sleeping Pills Sales by Manufacturers (2021-2026)
- 3.3 Global Sleeping Pills Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Sleeping Pills Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Sleeping Pills Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Sleeping Pills Manufacturers, Product Type & Application
- 3.7 Global Sleeping Pills Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Sleeping Pills Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Sleeping Pills Players Market Share by Revenue in 2025
- 3.8.3 2025 Sleeping Pills Tier 1, Tier 2, and Tier 3
4 Sleeping Pills Market by Type
- 4.1 Sleeping Pills Type Introduction
- 4.1.1 Adapin (doxepin)
- 4.1.2 Ativan (lorazepam)
- 4.1.3 Ramelteon (Rozerem)
- 4.1.4 Eszopiclone (Lunesta)
- 4.1.5 Zolpidem
- 4.2 Global Sleeping Pills Sales by Type
- 4.2.1 Global Sleeping Pills Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Sleeping Pills Sales by Type (2021-2032)
- 4.2.3 Global Sleeping Pills Sales Market Share by Type (2021-2032)
- 4.3 Global Sleeping Pills Revenue by Type
- 4.3.1 Global Sleeping Pills Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Sleeping Pills Revenue by Type (2021-2032)
- 4.3.3 Global Sleeping Pills Revenue Market Share by Type (2021-2032)
5 Sleeping Pills Market by Application
- 5.1 Sleeping Pills Application Introduction
- 5.1.1 Hospital Pharmacy
- 5.1.2 Retail Pharmacy
- 5.2 Global Sleeping Pills Sales by Application
- 5.2.1 Global Sleeping Pills Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Sleeping Pills Sales by Application (2021-2032)
- 5.2.3 Global Sleeping Pills Sales Market Share by Application (2021-2032)
- 5.3 Global Sleeping Pills Revenue by Application
- 5.3.1 Global Sleeping Pills Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Sleeping Pills Revenue by Application (2021-2032)
- 5.3.3 Global Sleeping Pills Revenue Market Share by Application (2021-2032)
6 Global Sleeping Pills Sales by Region
- 6.1 Global Sleeping Pills Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Sleeping Pills Sales by Region (2021-2032)
- 6.2.1 Global Sleeping Pills Sales by Region (2021-2026)
- 6.2.2 Global Sleeping Pills Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Sleeping Pills Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Sleeping Pills Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Sleeping Pills Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Sleeping Pills Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Sleeping Pills Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Sleeping Pills Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Sleeping Pills Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Sleeping Pills Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Sleeping Pills Revenue by Region
- 7.1 Global Sleeping Pills Revenue by Region
- 7.1.1 Global Sleeping Pills Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Sleeping Pills Revenue by Region (2021-2026)
- 7.1.3 Global Sleeping Pills Revenue by Region (2027-2032)
- 7.1.4 Global Sleeping Pills Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Sleeping Pills Revenue (2021-2032)
- 7.2.2 North America Sleeping Pills Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Sleeping Pills Revenue (2021-2032)
- 7.3.2 Europe Sleeping Pills Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Sleeping Pills Revenue (2021-2032)
- 7.4.2 Asia-Pacific Sleeping Pills Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Sleeping Pills Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Sleeping Pills Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Abbott Laboratories
- 8.1.1 Abbott Laboratories Company Information
- 8.1.2 Abbott Laboratories Business Overview
- 8.1.3 Abbott Laboratories Sleeping Pills Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Abbott Laboratories Sleeping Pills Product Portfolio
- 8.1.5 Abbott Laboratories Recent Developments
- 8.2 Takeda Pharmaceutical
- 8.2.1 Takeda Pharmaceutical Company Information
- 8.2.2 Takeda Pharmaceutical Business Overview
- 8.2.3 Takeda Pharmaceutical Sleeping Pills Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Takeda Pharmaceutical Sleeping Pills Product Portfolio
- 8.2.5 Takeda Pharmaceutical Recent Developments
- 8.3 Sanofi
- 8.3.1 Sanofi Company Information
- 8.3.2 Sanofi Business Overview
- 8.3.3 Sanofi Sleeping Pills Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Sanofi Sleeping Pills Product Portfolio
- 8.3.5 Sanofi Recent Developments
- 8.4 Hayao
- 8.4.1 Hayao Company Information
- 8.4.2 Hayao Business Overview
- 8.4.3 Hayao Sleeping Pills Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Hayao Sleeping Pills Product Portfolio
- 8.4.5 Hayao Recent Developments
- 8.5 Cayman Chemical
- 8.5.1 Cayman Chemical Company Information
- 8.5.2 Cayman Chemical Business Overview
- 8.5.3 Cayman Chemical Sleeping Pills Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Cayman Chemical Sleeping Pills Product Portfolio
- 8.5.5 Cayman Chemical Recent Developments
- 8.6 Aurobindo Pharma
- 8.6.1 Aurobindo Pharma Company Information
- 8.6.2 Aurobindo Pharma Business Overview
- 8.6.3 Aurobindo Pharma Sleeping Pills Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Aurobindo Pharma Sleeping Pills Product Portfolio
- 8.6.5 Aurobindo Pharma Recent Developments
- 8.7 Apotex
- 8.7.1 Apotex Company Information
- 8.7.2 Apotex Business Overview
- 8.7.3 Apotex Sleeping Pills Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Apotex Sleeping Pills Product Portfolio
- 8.7.5 Apotex Recent Developments
- 8.8 Ambitropin
- 8.8.1 Ambitropin Company Information
- 8.8.2 Ambitropin Business Overview
- 8.8.3 Ambitropin Sleeping Pills Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Ambitropin Sleeping Pills Product Portfolio
- 8.8.5 Ambitropin Recent Developments
- 8.9 Allegiant Health
- 8.9.1 Allegiant Health Company Information
- 8.9.2 Allegiant Health Business Overview
- 8.9.3 Allegiant Health Sleeping Pills Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Allegiant Health Sleeping Pills Product Portfolio
- 8.9.5 Allegiant Health Recent Developments
- 8.10 Actellon Pharmaceuticals
- 8.10.1 Actellon Pharmaceuticals Company Information
- 8.10.2 Actellon Pharmaceuticals Business Overview
- 8.10.3 Actellon Pharmaceuticals Sleeping Pills Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Actellon Pharmaceuticals Sleeping Pills Product Portfolio
- 8.10.5 Actellon Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Sleeping Pills Value Chain Analysis
- 9.1.1 Sleeping Pills Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Sleeping Pills Production Mode & Process
- 9.2 Sleeping Pills Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Sleeping Pills Distributors
- 9.2.3 Sleeping Pills Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst